secwatch.observer — SEC 8-K summary
======================================

Issuer:     ULTRALIFE CORP (ULBI)
CIK:        0000875657
Form:       8-K
Filed at:   2023-07-27T23:59:59+00:00
Accession:  0001437749-23-020793
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ultralife Q2 revenue $42.7M (+33% YoY); operating income $3.7M vs $0.8M; backlog record $110.9M
--------------------------------------------------------------------------------

- Revenue $42.7M, up 32.9% YoY; operating income $3.7M vs $0.8M YoY.
- Adjusted EPS $0.29 vs $0.03 YoY; GAAP net income $3.3M ($0.21 diluted EPS).
- Backlog reached record $110.9M, up 40.1% YoY; $76.4M expected to ship in H2 2023.
- Government/defense sales up 111.5%; Communications Systems sales more than quadrupled to $8.8M.
- Gross margin 24.8% vs 23.8% YoY; Battery & Energy margin declined to 22.3% due to cyber-attack effects.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/875657/000143774923020793/0001437749-23-020793-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/875657/000143774923020793/ulbi20230726c_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-020793

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer